Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating cash flow | ||||||||||||||||
net loss | -532,646 | 30,326,996 | -30,395,000 | -180,315,000 | -45,554,000 | -74,438,000 | -48,080,000 | -58,328,000 | -29,734,000 | -35,610,000 | -47,190,000 | -49,630,000 | ||||
adjustments to reconcile net loss to operating cash flow: | ||||||||||||||||
depreciation and amortization | ||||||||||||||||
equity-based compensation expense | 4,798 | -4,448,303 | 4,458,000 | 3,200,000 | 3,946,000 | 4,278,000 | 2,218,000 | 4,140,000 | 4,009,000 | 4,453,000 | 3,637,000 | 3,614,000 | 3,585,000 | |||
disposal of property, plant and equipment | 0 | |||||||||||||||
impairment of intangible asset | 0 | 0 | 0 | 71,000 | ||||||||||||
gain on insurance proceeds received for damage to property, plant and equipment | 0 | |||||||||||||||
change in fair value of warrant liabilities | 170,030,000 | 7,191,000 | -6,460,000 | -11,076,000 | ||||||||||||
other changes in assets and liabilities: | ||||||||||||||||
prepaid expenses and other assets | -11,549 | 228,400 | -229,000 | 7,939,000 | 798,000 | 2,955,000 | 4,721,000 | 8,334,000 | -15,810,000 | -2,468,000 | -99,000 | 7,542,000 | -7,188,000 | |||
accounts and other receivables | -2,394 | -7,757,690 | 7,766,000 | |||||||||||||
long-lead material work in process | 1,032 | -3,956,000 | -5,596,000 | |||||||||||||
long-lead material liability | 0 | -737,000 | 619,000 | |||||||||||||
accounts payable and accrued expenses | 337,850 | 1,308,222 | -1,292,000 | 7,761,000 | -1,771,000 | -1,616,000 | 1,343,000 | 9,416,000 | 8,503,000 | 497,000 | -170,000 | -3,812,000 | 5,010,000 | |||
nonrefundable customer deposit | ||||||||||||||||
net change in right of use assets and lease liabilities | -53 | 51,897 | -52,000 | |||||||||||||
deferred revenue | 469 | 21,700 | -22,000 | 865,000 | 0 | 41,000 | -861,000 | -32,483,000 | 9,602,000 | 22,701,000 | 222,000 | -275,000 | 337,000 | |||
accrued compensation | 2,401 | 1,722,970 | -1,724,000 | -419,000 | 2,015,000 | 321,000 | -3,133,000 | -873,000 | 3,185,000 | -39,000 | -2,596,000 | -14,000 | 3,406,000 | |||
net cash from operating activities | -199,799 | 22,729,893 | -22,786,000 | -26,417,000 | -12,728,000 | -36,032,000 | -33,489,000 | -73,212,000 | -27,675,000 | -39,230,000 | -43,137,000 | -43,881,000 | -40,676,000 | -63,643,460 | -408,540 | |
capital expenditures | 0 | 0 | -67,000 | 0 | 0 | 0 | -51,000 | -54,000 | -1,269,000 | -351,000 | -588,000 | -163,000 | 0 | 0 | ||
free cash flows | -199,799 | 22,729,893 | -22,853,000 | -26,417,000 | -12,728,000 | -36,032,000 | -73,263,000 | -27,729,000 | -40,499,000 | -43,488,000 | -44,469,000 | -40,839,000 | -63,643,460 | -408,540 | ||
investing cash flow | ||||||||||||||||
proceeds from sale of short-term investments | ||||||||||||||||
proceeds from sale of investments | ||||||||||||||||
purchase of short-term investments | -243,937 | 9,896,949 | -10,000,000 | -20,000,000 | ||||||||||||
purchase of investments | -36,799 | |||||||||||||||
purchase of property, plant and equipment | ||||||||||||||||
insurance proceeds received for damage to property, plant and equipment | 0 | |||||||||||||||
net cash from investing activities | 9,933,000 | -51,000 | -54,000 | -1,269,000 | 49,649,000 | -588,000 | -50,163,000 | |||||||||
financing cash flow | ||||||||||||||||
proceeds from the issuance of common stock, net of issuance fees | 462,613 | -99,657,243 | 99,757,000 | 100,806,000 | 31,201,000 | 31,027,000 | 41,614,000 | 1,969,000 | ||||||||
proceeds from exercise of common share options | 1,189 | -2,957,292 | 2,962,000 | |||||||||||||
net cash from financing activities | 463,802 | -102,614,535 | 102,719,000 | 311,389,000 | 38,422,000 | 34,781,000 | 45,214,000 | 1,994,000 | 9,762,000 | 2,754,000 | 1,617,000 | 1,178,000 | 27,524,000 | |||
net change in cash, cash equivalents and restricted cash | 109,890 | -89,969,861 | 89,866,000 | 289,928,000 | -19,306,000 | -71,269,000 | ||||||||||
cash, cash equivalents and restricted cash: | ||||||||||||||||
beginning of period | 0 | -406,249,344 | 406,656,000 | 0 | 0 | 0 | 125,365,000 | 0 | 0 | 0 | 244,217,000 | 0 | 0 | |||
end of period | 109,890 | -496,219,205 | 496,522,000 | 289,928,000 | -19,306,000 | -1,056,000 | 137,090,000 | -71,269,000 | -17,967,000 | -37,745,000 | 252,346,000 | -43,291,000 | -63,315,000 | |||
summary of noncash investing and financing activities: | ||||||||||||||||
accrued foreign income tax withholding to noncontrolling interests | 0 | -415,584 | 416,000 | |||||||||||||
plant, property and equipment in accounts payable | 65,000 | |||||||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||
foreign income taxes paid | 0 | -1,598,400 | 1,600,000 | |||||||||||||
depreciation | -268,471 | 269,000 | 379,000 | 394,000 | 402,000 | 490,000 | 567,000 | 641,000 | 557,000 | 615,000 | 640,000 | 666,000 | ||||
amortization of intangibles | -43,911 | 44,000 | 44,000 | 44,000 | 45,000 | 44,000 | 44,000 | 44,000 | 45,000 | 44,000 | 44,000 | 44,000 | ||||
sale of short-term investments | -19,980,000 | 20,000,000 | 0 | 0 | 50,000,000 | |||||||||||
net cash (used) provided by investing activities | 4,956,000 | |||||||||||||||
loss on disposal of plant property and equipment | ||||||||||||||||
long-term contract work in process | -1,609,000 | -382,000 | ||||||||||||||
purchases of property, plant and equipment | -67,000 | -51,000 | -54,000 | -1,269,000 | -351,000 | -588,000 | -163,000 | |||||||||
provision for credit losses | 943,000 | |||||||||||||||
loss on disposal of property, plant and equipment | 73,000 | |||||||||||||||
net noncash change in right of use assets and lease liabilities | 206,000 | -87,000 | -97,000 | -90,000 | -2,130,000 | -240,000 | 355,000 | -345,000 | -6,946,000 | 8,528,000 | ||||||
changes in assets and liabilities: | ||||||||||||||||
accounts receivable | -3,272,000 | 5,024,000 | 10,063,000 | 4,730,000 | -3,928,000 | -9,793,000 | 11,615,000 | -7,813,000 | ||||||||
lease liability | -410,000 | -403,000 | -401,000 | -398,000 | -411,000 | -570,000 | -570,000 | -150,000 | -238,000 | -454,000 | ||||||
deferred doe cost share | 0 | 0 | ||||||||||||||
insurance proceeds for property, plant and equipment | ||||||||||||||||
proceeds from exercise of warrants | ||||||||||||||||
foreign income tax withholding to nci interests | ||||||||||||||||
proceeds from transaction | 0 | 0 | ||||||||||||||
payments of transaction costs | 0 | 0 | ||||||||||||||
proceeds from exercise of common unit options | 0 | 0 | ||||||||||||||
repurchase of common units | 0 | 0 | ||||||||||||||
issuance of treasury units | 0 | 0 | ||||||||||||||
assumption of transaction warrant liabilities | 0 | 0 | ||||||||||||||
debt converted to equity | 0 | 0 | ||||||||||||||
warrants converted into equity | 0 | |||||||||||||||
conversion of equity options to liability award | 0 | 0 | ||||||||||||||
cash paid for income taxes | ||||||||||||||||
proceeds from exercise of warrants and common share options | 7,221,000 | 3,754,000 | 3,600,000 | 25,000 | 1,895,000 | 2,754,000 | 1,617,000 | 1,178,000 | ||||||||
change in the fair value of warrant liabilities | 9,045,000 | 1,108,000 | ||||||||||||||
net increase in cash, cash equivalents and restricted cash | 11,725,000 | 8,129,000 | -43,291,000 | |||||||||||||
net income | -15,958,891 | 8,734,669 | ||||||||||||||
adjustments to reconcile net income to operating cash flow: | ||||||||||||||||
accrued interest on convertible note payable | ||||||||||||||||
sale (purchase) of short-term investments | ||||||||||||||||
repayment of debt | ||||||||||||||||
proceeds from short-term borrowings | ||||||||||||||||
repayment of short-term borrowings | ||||||||||||||||
proceeds from sale of convertible preferred units | ||||||||||||||||
equity issuance fees | ||||||||||||||||
conversion of accounts payable to convertible preferred units | ||||||||||||||||
cash paid for interest | ||||||||||||||||
cfpp liability | ||||||||||||||||
purchases of short-term investments | ||||||||||||||||
net change in cash and cash equivalents | ||||||||||||||||
cash and cash equivalents: | ||||||||||||||||
cash, cash equivalents and restricted cash | ||||||||||||||||
long-term contract work in process in accounts payable | 16,018,000 | |||||||||||||||
proceeds from debt issuance | ||||||||||||||||
capital expenditures in accounts payable | ||||||||||||||||
increase in lease liability | ||||||||||||||||
increase in the fair value of warrant liabilities | ||||||||||||||||
net increase in cash and cash equivalents | ||||||||||||||||
| 2,022 | |||||||||||||||
cash flows from operating activities: | ||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
change in fair value of derivative warrant liabilities | 10,835,000 | |||||||||||||||
income from investments held in trust account | -23,395 | |||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||
prepaid expenses | 27,803 | |||||||||||||||
related party receivable | ||||||||||||||||
accounts payable | -195,091 | |||||||||||||||
accrued expenses | 4,906,034 | |||||||||||||||
cash flows from financing activities: | ||||||||||||||||
payment of offering costs | ||||||||||||||||
net change in cash | -408,540 | |||||||||||||||
cash - beginning of the period | 985,114 | |||||||||||||||
cash - ending of the period | 576,574 | |||||||||||||||
basic and diluted net income per ordinary share: | ||||||||||||||||
numerator: | ||||||||||||||||
allocation of net income | -12,767,113 | |||||||||||||||
denominator: | ||||||||||||||||
basic and diluted weighted-average ordinary shares outstanding | 23,000,000 | |||||||||||||||
basic and diluted net income per ordinary share | -0.56 | |||||||||||||||
change in fair value of derivative liabilities | ||||||||||||||||
gain on marketable securities (net), dividends and interest, held in trust account | ||||||||||||||||
formation and operating cost paid through the issuance of ordinary shares to sponsor | ||||||||||||||||
advances from related party | ||||||||||||||||
offering costs paid | ||||||||||||||||
net decrease in cash | ||||||||||||||||
cash - beginning of period | ||||||||||||||||
cash - end of period | ||||||||||||||||
supplemental disclosure of noncash investing and financing activities: | ||||||||||||||||
initial classification of class a ordinary shares subject to possible redemption | ||||||||||||||||
accretion of class a ordinary shares to redemption value | ||||||||||||||||
deferred offering costs included in accrued expenses | ||||||||||||||||
deferred offering costs paid through promissory note — related party | ||||||||||||||||
deferred offering costs paid through the issuance of ordinary shares to sponsor | ||||||||||||||||
balance sheet | ||||||||||||||||
ordinary shares subject to possible redemption | ||||||||||||||||
shareholders’ equity | ||||||||||||||||
preference shares - 0.0001 par value | ||||||||||||||||
class a ordinary shares - 0.0001 par value | ||||||||||||||||
class b ordinary shares - 0.0001 par value | ||||||||||||||||
additional paid-in-capital | ||||||||||||||||
accumulated deficit | ||||||||||||||||
total shareholders’ equity | ||||||||||||||||
offering costs allocated to derivative warrant liabilities | ||||||||||||||||
payment of formation costs through issuance of class b ordinary shares | ||||||||||||||||
cash flows from investing activities | ||||||||||||||||
cash deposited in trust account | ||||||||||||||||
proceeds from sale of units, net of underwriting discounts paid and reimbursements | ||||||||||||||||
proceeds from sale of private placement warrants | ||||||||||||||||
repayment of promissory note-related party | ||||||||||||||||
supplemental disclosure of noncash financing activities: | ||||||||||||||||
warrant liabilities in connection with initial public offering | ||||||||||||||||
deferred underwriting fee payable | ||||||||||||||||
accrued offering costs | ||||||||||||||||
offering costs paid by sponsor in exchange for founder shares | ||||||||||||||||
offering costs paid directly through note payable | ||||||||||||||||
change in value of class a ordinary shares subject to possible redemption | ||||||||||||||||
redeemable class a ordinary shares | ||||||||||||||||
numerator: earnings allocable to redeemable class a ordinary shares | ||||||||||||||||
less: income and franchise tax | ||||||||||||||||
net earnings allocable to redeemable class a ordinary shares | ||||||||||||||||
denominator: weighted-average share outstanding, redeemable class a ordinary shares | ||||||||||||||||
basic and diluted weighted-average shares outstanding, redeemable class a | ||||||||||||||||
basic and diluted net earnings per share, redeemable class a | ||||||||||||||||
non-redeemable class b ordinary shares | ||||||||||||||||
numerator: net income minus redeemable net earnings | ||||||||||||||||
less: net earnings allocable to redeemable class a ordinary shares | ||||||||||||||||
net income attributable to non-redeemable class b ordinary shares | ||||||||||||||||
denominator: weighted-average non-redeemable class b ordinary shares | ||||||||||||||||
basic and diluted weighted-average shares outstanding, non-redeemable class b | ||||||||||||||||
basic and diluted net income per share, non-redeemable class b | ||||||||||||||||
redemable class a ordinary shares | ||||||||||||||||
interest income | 5,729 | |||||||||||||||
net earnings | 5,729 | |||||||||||||||
denominator: weighted-average redeemable class a ordinary shares | ||||||||||||||||
redeemable class a common stock, basic and diluted | 23,000,000 | |||||||||||||||
earnings/basic and diluted redeemable class a ordinary share | ||||||||||||||||
redeemable net earnings | 5,729 | |||||||||||||||
non-redeemable net income | 8,740,398 | |||||||||||||||
non-redeemable class b ordinary shares, basic and diluted | 5,750,000 | |||||||||||||||
income/basic and diluted non-redeemable class b ordinary share | 1.52 | |||||||||||||||
redemable class a common stock | ||||||||||||||||
numerator: earnings allocable to redeemable class a common stock | ||||||||||||||||
income and franchise tax | ||||||||||||||||
denominator: weighted-average redeemable lass a common stock | ||||||||||||||||
earnings/basic and diluted redeemable class a common stock | ||||||||||||||||
non-redeemable class b common stock | ||||||||||||||||
denominator: weighted-average non-redeemable class b common stock | ||||||||||||||||
non-redeemable class b common stock, basic and diluted | ||||||||||||||||
loss/basic and diluted non-redeemable class b common stock |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
